A Case Study for CPP 
Diagnosis and Treatment With a Twice-yearly GnRH Agonist

Yes, this is standard protocol where I practice

Yes, insurance requires that we do

Usually only if a patient’s random luteinizing hormone values are <0.3 IU/L

No, not usually

A yearly implant

Monthly injections

Injections given every 3 months

Injections given every 6 months

Another option

Clinical measures, such as height, Tanner stage, and bone age

Biochemical measures, such as luteinizing hormone levels (random and/or simulated)

Both clinical and biochemical measures

Some other way